Data completeness
1/8 — Limited
LOCOID (hydrocortisone butyrate) by Precision BioSciences is clinical pharmacology topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions.
Drug data last refreshed 15h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID (hydrocortisone butyrate) is a topical corticosteroid ointment that reduces inflammation, itching, and vasodilation through unclear but well-established anti-inflammatory mechanisms. It is applied directly to inflamed skin conditions and is absorbed through the skin, where it undergoes hepatic metabolism similar to systemic corticosteroids. The product is indicated for inflammatory and pruritic dermatological conditions responsive to topical corticosteroid therapy.
Pre-Launch
Pre-launch status indicates incoming commercial buildout with opportunity for early-stage brand development, field team expansion, and market access roles.
Mechanism of Action
CLINICAL PHARMACOLOGY Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on LOCOID at Precision BioSciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.